China Pharma Holdings (CPHI) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for China Pharma Holdings (CPHI) over the last 11 years, with Q3 2025 value amounting to -$0.17.
- China Pharma Holdings' EPS (Weighted Average and Diluted) rose 7384.62% to -$0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.41, marking a year-over-year increase of 16184.21%. This contributed to the annual value of -$0.27 for FY2024, which is 7032.97% up from last year.
- Latest data reveals that China Pharma Holdings reported EPS (Weighted Average and Diluted) of -$0.17 as of Q3 2025, which was up 7384.62% from -$0.16 recorded in Q2 2025.
- China Pharma Holdings' 5-year EPS (Weighted Average and Diluted) high stood at $1.98 for Q4 2024, and its period low was -$0.89 during Q2 2024.
- In the last 3 years, China Pharma Holdings' EPS (Weighted Average and Diluted) had a median value of -$0.24 in 2025 and averaged -$0.13.
- Examining YoY changes over the last 5 years, China Pharma Holdings' EPS (Weighted Average and Diluted) showed a top increase of 1000000.0% in 2024 and a maximum decrease of 12413.79% in 2024.
- Over the past 3 years, China Pharma Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.02 in 2023, then skyrocketed by 10000.0% to $1.98 in 2024, then plummeted by 108.59% to -$0.17 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.17 in Q3 2025, compared to -$0.16 in Q2 2025 and -$0.24 in Q1 2025.